AI assistant
Sending…
Cibus, Inc. — Director's Dealing 2023
Jun 2, 2023
34396_dirs_2023-06-01_e91aa312-84e4-4a81-9c8a-1a7576c32ae3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cibus, Inc. (CLXT)
CIK: 0001705843
Period of Report: 2023-03-01
Reporting Person: Ribeill Yves J (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-03-01 | Stock Option (Right-to-Buy) | $4.55 | D | 25000 | Disposed | 2030-08-04 | Common Stock (25000) | Direct |
| 2023-03-01 | Stock Option (Right-to-Buy) | $4.55 | A | 25000 | Acquired | 2030-08-04 | Common Stock (25000) | Direct |
| 2023-03-01 | Stock Option (Right-to-Buy) | $4.22 | D | 10291 | Disposed | 2031-05-27 | Common Stock (10291) | Direct |
| 2023-03-01 | Stock Option (Right-to-Buy) | $4.22 | A | 10291 | Acquired | 2031-05-27 | Common Stock (10291) | Direct |
| 2023-03-01 | Stock Option (Right-to-Buy) | $0.3032 | D | 47200 | Disposed | 2032-06-13 | Common Stock (47200) | Direct |
| 2023-03-01 | Stock Option (Right-to-Buy) | $0.3032 | A | 47200 | Acquired | 2032-06-13 | Common Stock (47200) | Direct |
Footnotes
F1: Teh reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split of its common stock on May 31, 2023. Amounts reported above are pre-split.
More from Cibus, Inc.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Annual Report
2026
Apr 20
Proxy Solicitation & Information Statement
2026
Apr 20
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 18